natgillin/translations-raw huggingface dataset:
The full EPAR for Uptravi can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Uptravi nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Urorec can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Urorec nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Valdoxan can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Cjeloviti EPAR za lijek Valdoxan nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
The full EPAR for Vantavo can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Cjeloviti EPAR za lijek Vantavo nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Vectibix can be found on the Agency’s website ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Cjeloviti EPAR za Vectibix nalazi se na internetskim stranicama Agencije ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
The full EPAR for Vectormune ND can be found on the Agency’s website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Cjeloviti EPAR za VMP Vectormune ND nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
The full EPAR for Velactis can be found on the Agency’s website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Cjeloviti EPAR za VMP Velactis nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
The full EPAR for Velcade can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Cjelovito Europsko javno izvješće o procjeni (EPAR) lijeka Velcade nalazi se na internetskim stranicama Agencije ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
The full EPAR for Ventavis can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku (EPAR) nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
The full EPAR for Vepacel can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku (EPAR) za lijek Vepacel nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
The full EPAR for Vfend can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku (EPAR) za lijek Vfend nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
The full EPAR for Viagra can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Viagra nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Vibativ can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Cjeloviti EPAR za lijek Vibativ nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
The full EPAR for Victoza can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Vidaza can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Vidaza nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Vipidia can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku (EPAR) za lijek Vipidia može se naći na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Viread can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku (EPAR) za lijek Viread nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
The full EPAR for Visudyne can be found can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Visudyne nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Vitekta can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku (EPAR) za lijek Vitekta nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Volibris can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku (EPAR) za lijek Volibris nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Voriconazole Accord can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za Voriconazole Accord nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Vpriv can be found on the Agency’s website under EMA website/Find medicine/Human medicines/European Public Assessment Reports.
Cjeloviti EPAR za lijek Vpriv nalazi se na internetskim stranicama Agencije: EMA website/Find medicine/Human medicines/European Public Assessment Reports.
The full EPAR for Vyndaqel can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Cjeloviti EPAR za lijek Vyndaqel nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
The full EPAR for Xagrid can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR kao i sažetak plana upravljanja rizikom za lijek Xagrid nalaze se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Xalkori can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Xalkori nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Xeloda can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Xeloda nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Xgeva can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Cjeloviti EPAR za lijek Xgeva nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
The full EPAR for Xiapex can be found on the Agency’s website ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Cjeloviti EPAR za lijek Xiapex nalazi se na internetskim stranicama Agencije ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
The full EPAR for Xofigo can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjelovito Europsko javno izvješće o ocjeni dokumentacije (EPAR) za lijek Xofigo može se naći na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Xolair can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku (EPAR) za lijek Xolair nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Xoterna Breezhaler can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku (EPAR) za Xoterna Breezhaler može se naći na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Xtandi can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Xtandi nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Xyrem can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku Xyrem (EPAR) može se naći na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
The full EPAR for Yervoy can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku (EPAR) za Yervoy može se naći na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
The full EPAR for ZACTRAN can be found on the Agency’s website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Cjeloviti EPAR za lijek ZACTRAN nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
The full EPAR for Zalmoxis can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Zalmoxis nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Zarzio can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Zarzio nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Zavicefta can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Zavicefta nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Zeffix can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Zeffix nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Zepatier can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Zepatier nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Zerit can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Cjeloviti EPAR za lijek Zerit nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
The full EPAR for Ziagen can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Ziagen nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Zinbryta can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Zinbryta nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Zinforo can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Zinforo nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Zoely can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Cjeloviti EPAR za lijek Zoely nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
The full EPAR for Zoledronic Acid Accord can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku (EPAR) za lijek Zoledronatna kiselina Accord može se naći na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Zoledronic Acid Hospira can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku (EPAR) za Zoledronatnu kiselinu Hospira nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Zoledronic acid Teva can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za zoledronatnu kiselinu Teva nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Zometa can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Zometa nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Zonegran can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku (EPAR) za Zonegran može se naći na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Zonisamide Mylan can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Zonisamid Mylan nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Zostavax is available on the Agency’s website ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Cjeloviti EPAR za lijek Zostavax nalazi se na internetskim stranicama Agencije ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
The full EPAR for Zulvac SBV can be found on the Agency’s website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Cjeloviti EPAR za Zulvac SBV nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
The full EPAR for Zutectra can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Zutectra nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Zycortal can be found on the Agency’s website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Cjeloviti EPAR za VMP Zycortal nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
The full EPAR for Zydelig can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Zydelig nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR for Zykadia can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjeloviti EPAR za lijek Zykadia nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full EPAR summary for Xigduo can be found on the Agency’s website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Cjelovito Europsko javno izvješće o procjeni (EPAR) lijeka Xigduo nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The full list of bacteria against which Zinforo is active can be found in the summary of product characteristics (also part of the EPAR).
Potpuni popis bakterija protiv kojih lijek Zinforo djeluje dostupan je u sažetku opisa svojstava lijeka (također dio EPAR-a).
The full name of your medicine is Myclausen 500 mg film-coated tablets.
Puno ime Vašeg lijeka je Myclausen 500 mg filmom obložene tablete.
The full recommended dose of the vaccine should be used.
Potrebno je primijeniti cijelu preporučenu dozu cjepiva.
The full recommended dose of the vaccine should be used.
Potrebno je primijeniti cijelu preporučenu dozu.
The functional antibody (OPA) geometric mean titres for serotypes 1, 3 and 5 were lower than the titres for each of the other additional serotypes; the clinical relevance of this observation for protective efficacy is unknown.
Geometrijska sredina vrijednosti titra funkcionalnih protutijela (OPA) na serotipove 1, 3 i 5 bio je niži od titra protutijela na svaki od preostalih dodatnih serotipova; nije poznata klinička važnost ovog nalaza u pogledu djelotvornosti zaštite.
The functioning of your thyroid gland will be checked regularly or whenever thought necessary by your doctor for other reasons.
Funkcioniranje Vaše štitne žlijezde provjeravat će se redovito ili kadgod to Vaš liječnik bude smatrao potrebnim iz drugih razloga.
The functioning of your thyroid gland will be checked regularly or whenever thought necessary by your doctor for other reasons.
Redovito će se provjeravati funkcioniranje Vaše štitne žlijezde ili u bilo kojem trenutku kada Vaš liječnik to procijeni potrebnim iz drugih razloga.
The fundamental requirement of the treatment of periodontal disease is mechanical and/or surgical intervention by the veterinarian.
Temeljna je potreba pri liječenju periodontalnih bolesti mehanička i/ili kirurška intervencija veterinara.
The FXIII B-subunit acts as a carrier molecule for the FXIII A-subunit in circulation, and is present in excess in plasma.
FXIII B-podjedinica djeluje kao molekula nosač za FXIII A-podjedinicu u cirkulaciji i prisutna je u većoj količini u plazmi.
The gas cylinder should be put in an equipped site with appropriate material in order to hold the gas cylinder vertically.
Spremnik s plinom mora se postaviti na mjesto s odgovarajućom opremom koja osigurava njegovo čuvanje u okomitom položaju.
the gas cylinders should be fixedly stowed away in order to avoid untimely fall
premnici s plinom moraju biti fiksirani u okomitom položaju kako bi se izbjegla opasnost od pada
The gas cylinders should be stored in an airy, clean and locked place, for storage of medicinal gas only.
Spremnici za plin moraju se čuvati na prozračnom, čistom i zaključanom mjestu predviđenom za čuvanje samo medicinskih plinova.
The gas cylinders should be stored in an airy, clean and locked place, for storage of medicinal gas only.
Spremnike s plinom čuvati na prozračnom, čistom i zaključanom mjestu predviđenom za čuvanje samo medicinskih plinova.
The gas is removed naturally from the body through the lungs.
Plin se uklanja prirodnim putem iz tijela kroz pluća.
The gastro-resistant tablets are yellow, oval, biconvex film-coated tablets imprinted with “P20” on one side.
Želučanootporne tablete su žute, ovalne, bikonveksne, filmom obložene tablete sa smeđom oznakom "P20" na jednoj strani.
The Gazyvaro treatment Chronic lymphocytic leukaemia
Liječenje lijekom Gazyvaro Kronična limfocitna leukemija
The gE- (glycoprotein E negative) characteristic of the vaccine virus makes it possible to distinguish between antibodies induced by vaccination with this product and those induced by field infection with Aujeszky’s disease virus, if the vaccine is used in association with an appropriate diagnostic test.
Karakteristika virusa cjepiva gE- (glikoprotein E negativni) omogućuje razlikovanje protutijela induciranih cijepljenjem ovim proizvodom i protutijela induciranih terenskom infekcijom virusom bolesti Aujeszkoga ako se cjepivo primjenjuje uz odgovarajući dijagnostički test.
The gel can be administered to healthy skin around the lesions, whereas application near the eyes, nostrils, mouth, ears or mucosa should be avoided (keep a distance of 1 cm).
Gel se može nanijeti na zdravu kožu oko lezija, ali treba izbjegavati nanošenje blizu očiju, nosnica, usta, ušiju ili sluznice (na udaljenosti od 1 cm).
The gel is allowed to dry for approximately 10 minutes before placing a light-tight dressing over the treatment site.
Gel treba ostaviti da se osuši približno 10 minuta prije postavljanja laganog zavoja na mjesto liječenja.
The gel should be allowed to dry for approximately 10 minutes, before an occlusive light-tight dressing is placed over the treatment site.
Gel treba ostaviti da se osuši približno 10 minuta prije postavljanja laganog okluzivnog zavoja na mjesto liječenja.
The gel should be prepared at the patient’s bedside.
Gel se mora pripremiti uz krevet bolesnika.
The gelatin sponges should be handled and used according to the manufacturer’s instructions in the package insert that accompanies the gelatin sponge.
Želatinskim spužvicama treba rukovati i koristiti ih u skladu s uputama proizvođača sadržanima u uputi koja se isporučuje uz želatinsku spužvicu.
The GEMINI II Study was a randomised, double-blind, placebo-controlled study evaluating efficacy endpoints at Week 6 and Week 52.
Ispitivanje GEMINI II bilo je randomizirano, dvostruko slijepo, placebom kontrolirano ispitivanje za procjenu ishoda djelotvornosti u 6. i 52. tjednu.